Cisadane Sawit Raya Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Cisadane Sawit Raya Tbk trades at Rp765 (market cap 1.56T, 243.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.18M 24h volume). The key difference: Cisadane Sawit Raya Tbk is far larger — about 2.7× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.18M versus 243.1K). Which is the better fit depends on your goals.
| CSRA | LABS | |
|---|---|---|
Market Cap | 1.56T | 576.7B |
Volume | 243.1K | 3.18M |
Lot | 2.43K | 31.8K |
Turnover | 184.8M | 478.24M |
Average Price | 760.2 | 150.39 |
Value | 184.8M | 478.24M |
Indicative Equilibrium Price | 760 | 147 |
Indicative Equilibrium Volume | 1.5K | 311 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cisadane Sawit Raya Tbk (the Company) was established based on Notarial Deed No. 82 dated October 28, 1983 of Public Notary Erly Soehandjojo, S.H., amended by Notarial Deed No. 107 dated November 25, 1987 of Public Notary H.Z. Simon, S.H.
Read more on CSRA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →